Vaccines and Guillain-Barre syndrome

BMJ

Volumn 312, Issue 7044, 1996, Pages 1475-1476

  Hughes, Richard ^a   Rees, Jeremy ^a   Smeeton, Nigel ^a   Winer, John ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

GUILLAIN BARRE SYNDROME; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

HUMANS; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; POLYRADICULONEUROPATHY; RUBELLA VACCINE; VACCINES, COMBINED;

EID: 85047693794     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7044.1475d     Document Type: Letter

References (3)

1. Hughes RAC. Guillain-Barre syndrome. Heidelberg: Springer-Verlag, 1990.
2. Rees JH, Soudain SE, Gregson NA, Hughes RAC. A prospective case control study to investigate the relationship between Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 1995; 333: 1374–9.
3. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RFP. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51: 613–618.